CN102204926A - Nasal cavity cleaning agent - Google Patents
Nasal cavity cleaning agent Download PDFInfo
- Publication number
- CN102204926A CN102204926A CN201110145213XA CN201110145213A CN102204926A CN 102204926 A CN102204926 A CN 102204926A CN 201110145213X A CN201110145213X A CN 201110145213XA CN 201110145213 A CN201110145213 A CN 201110145213A CN 102204926 A CN102204926 A CN 102204926A
- Authority
- CN
- China
- Prior art keywords
- nasal cavity
- nasal
- cleaning agent
- cavity cleaning
- mucosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a nasal cavity cleaning agent applied to health care of the nasal cavity of a human body. The nasal cavity cleaning agent comprises the following components in percentage by weight: 0.9 to 1.2 percent of sea salt, 0.05 to 0.2 percent of buffering agent and the balance of water, wherein the buffering agent is prepared from citric acid and sodium citrate in the weight proportion of 1 to 100. The nasal cavity cleaning agent has the advantages that: the environment in the nasal cavity is maintained because of sodium chloride with the physical concentration and pH value; 2, secretions in the nasal cavity can be diluted and discharged, nose scabs are eliminated, and breath becomes smooth; 3, the nasal cavity is moisturized and bleeding caused by dryness of the nasal cavity is avoided; 4, pathogenic bacteria and harmful substances in the nasal cavity are cleaned and the automatic secreting and cleaning function of the nasal cavity is recovered; 5, nasal mucosa is protected and the ciliated epithelium of the nasal mucosa is promoted to swing; and 6, the nasal cavity cleaning agent does not have any adverse reaction and any side effect on human bodies because no chemical drug is contained in the nasal cavity cleaning agent.
Description
Technical field
The present invention relates to a kind of nasal cavity abluent that is used for the health care of human body nasal cavity.
Background technology
Nasal cavity is human respiratory tract's the outpost of the tax office, first road, and not only contains oxygen in the inhaled air, also has the spore of pathogenic microorganism such as antibacterial, fungus and virion etc., and along with increasing the weight of of atmospheric pollution, the dust of suspension and deleterious chemical particle also roll up.After these harmful substances were sucked by nasal cavity, nose utilized mechanism such as fibre swing, mucous secretion that the overwhelming majority is blocked in nasal cavity.When the harmful substance that sucks surpassed nasal cavity self cleaning capacity, the harmful substance of accumulation can stimulate nasal mucosa, causes discomfort, rhinorrhea, sneeze, nasal obstruction, inflammation or infection, threatened health.In addition, nasal cavity is usually owing to the delay of viscosity, purulent secretion forms dry crusts or caseous substance.They often block nasal cavity, influence the nasal cavity circulation of air, show as symptoms such as drying, scratchy, nasal obstruction, ozena, dizziness, headache, inappetence, insomnia clinically, by flushing, can remove dry crusts, caseous substance, the recovery nasal cavity cleaning is unobstructed, keep functions such as the moistening and normal olfactory sensation of nasal cavity, impel rhinitis sicca, the atrophic rhinitis, caseous rhinitis is cured, flushing nasal cavity and cavum nasopharyngeum can dash sensitizer from human body rapidly, alleviate the morbidity risk rate of allergic rhinitis, reduction allergic rhinitis.Have uncomfortable sensation when having the dryness in the nasal cavity crust in the nasal vestibule, if method is improper when removing, not only can influences personal image, and cause the nasal vestibule skin injury easily, vibrissa comes off, and also can cause consequences such as hemorrhage, infection when serious.Nasal cavity cleans can effectively improve this situation, and at present, nasal cavity cleans health care and adopts the physiological sea water as abluent usually, though it can play cleaning effect preferably, gentle inadequately when it acts on nasal cavity, the sense of discomfort of human body is stronger in the use.In addition, existing physiological sea water and human nasal intracavity environmental difference are bigger, are unfavorable for guaranteeing the normal function of nasal cavity.
Summary of the invention
Technical problem to be solved by this invention is, provide a kind of cleaning effect good, with nasal cavity good environmental adaptability, nasal cavity abluent that comfort is good.
The composition of nasal cavity abluent of the present invention and percentage by weight are: sea salt 0.9%～1.2%, buffer agent 0.05%～0.2%, all the other are water; Described buffer agent is formulated according to 1: 100 weight ratio by citric acid and sodium citrate.
Above-mentioned nasal cavity abluent of the present invention makes its pH value 6.0～8.0 by the addition of control buffer agent.
The main component of nasal douche is compositions such as sea salt, citric acid-sodium citrate buffer agent, the physiological sea water that is formed by sea salt has natural antiinflammatory, germ-resistant effect, can clean, moistening and protect nasal mucosa, make Ciliated epithelium's function normalization of nasal cavity, the nasal cavity flora had sterilization and bacteriostasis, compared to the more effective nasal cavity cleaning of normal saline; And in sea salt solution, add citric acid-sodium citrate buffer, and can regulate pH, make it to have the sodium chloride and the pH value of physiological concentration, be stabilized within the pH scope that is fit to the nasal cavity environment, nasal cavity is not stimulated, act on more comfortable.Nasal membrane goblet cell generation pH value is about 7.4 secretions, make the normal nasal discharge pH value of adult maintain 5.5～6.5, and the pH value of the secretions of the pH value of the nasal douche solution after use citric acid and the sodium citrate buffer agent adjusting and nasal mucosa cell is very approaching, thereby can keep the stable of nasal cavity environment.Through verification experimental verification, nasal douche of the present invention can adapt to the function of nasal mucosa, stimulate the respond of nasal cavity macrophage, impel and engulf factor increase and activate the phagocytic capacity enhancing, can improve the interior environment of nasal cavity, help to recover the secretory function of nasal cavity, the motor capacity of cilium, recover the normal ph of nasal mucosa.
Citric acid and sodium citrate as one of nasal douche composition are the additive of food stage, and be harmless, and sodium citrate plays the dash adjustment pH effect except cooperating citric acid, and itself also can play the effect of washing, antioxidation and chelating.It is comfortable that citric acid and sodium citrate carry out the buffer solution effect that the proportioning of science forms, can combine with pollutant such as the dust that enters nasal cavity, heavy metal ion, form the soluble chelating thing, the pollution abatement thing is to the stimulation of nasal mucosa and adhere to, simultaneously can improve the nasal cavity blood circulation, strengthen effects such as body immunity.
In sum, advantage applies of the present invention exists:
1 has the sodium chloride and the pH value of physiological concentration, keeps the nasal cavity environment;
2 can dilute the eliminating nasal secretion, dispel the nose crust, make breathing unimpeded;
3 moistening nasal cavities, avoid because of dry nasal cavity hemorrhage;
Pathogenic bacteria and harmful substance in 4 nasal cavity cleaning recover nasal cavity secretion and cleaning function automatically;
5 protection nasal mucosas promote nasal mucosa epithelium fibre swing;
6 nasal douche do not contain chemicals, do not have any untoward reaction, and human body is had no side effect.
The specific embodiment
The prescription of embodiments of the invention such as following table:
The foregoing description uses checking through the experimenter, and its effect is comfortable, for the effect of the effective alleviations of symptom such as nasal obstruction, rhinocnesmus, dryness in the nasal cavity, sneeze, rhinorrhea.
Claims (2)
1. nasal cavity abluent is characterized in that: its composition and percentage by weight be, sea salt 0.9%～1.2%, buffer agent 0.05%～0.2%, all the other are water; Described buffer agent is formulated according to the 1:100 weight ratio by citric acid and sodium citrate.
2. nasal cavity abluent according to claim 1 is characterized in that: this nasal cavity abluent makes its pH value 6.0～8.0 by the addition of control buffer agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110145213XA CN102204926A (en) | 2011-05-31 | 2011-05-31 | Nasal cavity cleaning agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110145213XA CN102204926A (en) | 2011-05-31 | 2011-05-31 | Nasal cavity cleaning agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102204926A true CN102204926A (en) | 2011-10-05 |
Family
ID=44694170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110145213XA Pending CN102204926A (en) | 2011-05-31 | 2011-05-31 | Nasal cavity cleaning agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102204926A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103385901A (en) * | 2012-05-07 | 2013-11-13 | 胡维民 | Powder directly used in nasal washing |
| CN105902555A (en) * | 2016-06-22 | 2016-08-31 | 张波 | Novel nasal irrigation composition and preparation method thereof |
| CN106038588A (en) * | 2016-07-11 | 2016-10-26 | 长春呈实健康实业有限公司 | Natural sea salt nasal irrigation agent |
| CN108721329A (en) * | 2018-06-12 | 2018-11-02 | 珠海市尼诺生物科技有限公司 | It is a kind of to be used to alleviate conditioning liquid of rhinitis and preparation method thereof |
| CN108743776A (en) * | 2018-05-16 | 2018-11-06 | 张罗 | A kind of flushing powder for nasal disease prevention |
| CN109718246A (en) * | 2019-02-19 | 2019-05-07 | 刘宝林 | A kind of nasal cavity cleaning liquid |
| CN110179816A (en) * | 2019-04-30 | 2019-08-30 | 苏州三昧火医疗器械有限公司 | One kind washing smelling salt |
| CN110507603A (en) * | 2019-09-12 | 2019-11-29 | 沈阳大得医疗器械产品有限公司 | A kind of solidification seawater gel and preparation method thereof |
| CN111544385A (en) * | 2020-06-11 | 2020-08-18 | 苏州三昧火医疗器械有限公司 | Nasal cavity cleaning liquid concentrate |
| CN113599448A (en) * | 2021-08-07 | 2021-11-05 | 武汉左点科技有限公司 | Moisturizing nasal wash and preparation method thereof |
| CN114159464A (en) * | 2020-09-10 | 2022-03-11 | 三鑫三淼(北京)生物科技有限公司 | Nasal wash and method for preparing nasal wash |
| CN116211884A (en) * | 2023-02-16 | 2023-06-06 | 海孵(海南自贸区)医疗科技有限责任公司 | Nasal cavity spray and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1358098A (en) * | 1999-06-30 | 2002-07-10 | 斯科特·科德雷 | Nasal spray having dead sea salts |
| CN1583172A (en) * | 2004-05-31 | 2005-02-23 | 刘近周 | Multifunctional liquid for clean therapy of nasal cavity and sinuses |
| CN1883508A (en) * | 2006-05-24 | 2006-12-27 | 吕爱民 | Anti-dust nasal cleanser |
-
2011
- 2011-05-31 CN CN201110145213XA patent/CN102204926A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1358098A (en) * | 1999-06-30 | 2002-07-10 | 斯科特·科德雷 | Nasal spray having dead sea salts |
| CN1583172A (en) * | 2004-05-31 | 2005-02-23 | 刘近周 | Multifunctional liquid for clean therapy of nasal cavity and sinuses |
| CN1883508A (en) * | 2006-05-24 | 2006-12-27 | 吕爱民 | Anti-dust nasal cleanser |
Non-Patent Citations (1)
| Title |
|---|
| ANANHEHE123456: "鼻可乐洗鼻剂", 《HTTP://BAIKE.BAIDU.COM/HISTORY/ID=13897810》, 28 July 2010 (2010-07-28), pages 1 - 3 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103385901A (en) * | 2012-05-07 | 2013-11-13 | 胡维民 | Powder directly used in nasal washing |
| CN105902555A (en) * | 2016-06-22 | 2016-08-31 | 张波 | Novel nasal irrigation composition and preparation method thereof |
| CN106038588A (en) * | 2016-07-11 | 2016-10-26 | 长春呈实健康实业有限公司 | Natural sea salt nasal irrigation agent |
| CN108743776A (en) * | 2018-05-16 | 2018-11-06 | 张罗 | A kind of flushing powder for nasal disease prevention |
| CN108721329B (en) * | 2018-06-12 | 2021-03-12 | 珠海市尼诺生物科技有限公司 | Nursing liquid for relieving rhinitis and preparation method thereof |
| CN108721329A (en) * | 2018-06-12 | 2018-11-02 | 珠海市尼诺生物科技有限公司 | It is a kind of to be used to alleviate conditioning liquid of rhinitis and preparation method thereof |
| CN109718246A (en) * | 2019-02-19 | 2019-05-07 | 刘宝林 | A kind of nasal cavity cleaning liquid |
| CN110179816A (en) * | 2019-04-30 | 2019-08-30 | 苏州三昧火医疗器械有限公司 | One kind washing smelling salt |
| CN110507603A (en) * | 2019-09-12 | 2019-11-29 | 沈阳大得医疗器械产品有限公司 | A kind of solidification seawater gel and preparation method thereof |
| CN111544385A (en) * | 2020-06-11 | 2020-08-18 | 苏州三昧火医疗器械有限公司 | Nasal cavity cleaning liquid concentrate |
| CN114159464A (en) * | 2020-09-10 | 2022-03-11 | 三鑫三淼(北京)生物科技有限公司 | Nasal wash and method for preparing nasal wash |
| CN113599448A (en) * | 2021-08-07 | 2021-11-05 | 武汉左点科技有限公司 | Moisturizing nasal wash and preparation method thereof |
| CN116211884A (en) * | 2023-02-16 | 2023-06-06 | 海孵(海南自贸区)医疗科技有限责任公司 | Nasal cavity spray and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102204926A (en) | Nasal cavity cleaning agent | |
| CN102657611B (en) | Sodium pyruvate nasal spray and preparation method thereof | |
| US5897872A (en) | Iodine-containing nasal moisturizing saline solution | |
| Bachmann et al. | Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease | |
| US6171611B1 (en) | Iodine-containing nasal moisturizing saline and mouthwash solutions | |
| CN103120703A (en) | Care solution for cleaning nasal cavity and related composition | |
| CN103096908B (en) | Nasal spray | |
| KR20100096108A (en) | Osmolyte-containing preparation for the treatment of dry mucous membranes | |
| ATE511847T1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GENITITAL TRACT | |
| CN106581148A (en) | Nasal irrigation care solution | |
| CN107899006A (en) | Pharmaceutical composition of nasal irrigation and preparation method thereof | |
| CN108743776A (en) | A kind of flushing powder for nasal disease prevention | |
| CN105079034A (en) | Preparation method of nasal nursing solution | |
| EP1817044A1 (en) | Composition comprising a polysaccharide with bacteria blocking action | |
| WO2015082965A2 (en) | Novel chitosan nasal wash | |
| CN105902555A (en) | Novel nasal irrigation composition and preparation method thereof | |
| CN105412913B (en) | A kind of nasal cavity wetting agent | |
| CN105381454B (en) | A kind of nasal cavity wetting agent containing trehalose | |
| CN105920094A (en) | Nasal cavity nursing composition, application thereof and obtained nasal cavity nursing product | |
| CN110279656B (en) | Composition for relieving nasal dryness and preparation method and using method thereof | |
| CN104606137A (en) | Antimicrobial repair-type nasal spray | |
| CA2852591C (en) | Vitamin d3 compositions and uses thereof for the treatment of nasal passages | |
| CN205648972U (en) | Gauze mask formula air cleaner | |
| WO2020142054A2 (en) | Nasal spray formulation | |
| CN211798338U (en) | Protective device for preventing respiratory tract infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20111005 |